Triphendiol also potently sensitizes pancreatic and bile duct cancer cell lines and xenograft tumors to the standard of care drug, gemcitabine. This study assessed the potential of triphendiol
These new solutions allow researchers to leverage synergies across Illumina technology platforms to better understand the complex molecular mechanisms that give rise to cancer. DASL Assay was specifically
The data were generated from a Phase III study that prospectively evaluated patients with biomarkers identified from earlier clinical studies. These results confirm the predictive value of p53
In vitro and in vivo studies of U3-1287 (AMG 888), which is being developed in partnership with Amgen, demonstrate that the antibody inhibits oncogenic signaling and proliferation of
The patent relates to Fosamax once weekly (alendronate 70mg once weekly). This favorable decision follows a similar judgment rendered by the Hague District Court in the Netherlands regarding
The trial investigated both prevention (n=288) and treatment (n=545) of Glucocorticoid-induced osteoporosis (GIO) in patients. Results demonstrated that a single yearly infusion of Reclast significantly increased bone mineral
As a result of the transaction, CollaGenex has become a wholly owned subsidiary of Galderma Laboratories. Upon closing of the acquisition, all remaining outstanding shares of CollaGenex common
To be eligible to participate in this study, a patient must have been diagnosed with prostate cancer that has recurred after completing treatment by external beam radiation therapy
These data are consistent with findings from preclinical oral bioavailability studies of picoplatin. The company also announced findings from a preclinical study demonstrating that picoplatin retains its activity
Teva has also been granted 180-day exclusivity for a generic version of Janssen Pharmaceutical’s Risperdal (risperidone) tablets, which is used for the treatment of schizophrenia. Teva expects final
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.